Cryoport Inc, CKXG:DEU profile

Price (EUR)15.00
Today's Change-0.80 / -5.06%
Shares traded700.00
1 Year change-29.91%
Beta--

Data delayed at least 15 minutes, as of May 03 2024.

More ▼

Add to Your Portfolio

Name

Currency

Profile data is unavailable for this security.

About the company

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

Revenue in USD (TTM)233.26m
Net income in USD-107.59m
Incorporated1990
Employees1.02k

Location
Cryoport Inc112 Westwood Place, Suite 350BRENTWOOD 37027United StatesUSA
Phone+1 (949) 232-1900
Fax+1 (949) 470-2306
Websitehttps://www.cryoport.com/

More ▼

Mergers & acquisitions

Acquired company	Deal status	Date	Date / Deal status	CYRX:NAQ since announced	Transaction value
Tec4med Lifescience GmbH	Deal completed	02 Nov 2023	02 Nov 2023Deal completed	67.54%	--

Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.

Income statement (USD)

Year on year Cryoport Inc's net income fell 166.75% from a loss of37.33m to a larger loss of 99.59m despite relatively flat revenues. A contributing factor has been the increase in the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percent of sales).

Explore our tools

Growth CalculatorBETA
Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes
Alerts
Create detailed alerts and get notified the moment an event happens
Watchlists
Monitor a select list of assets
Are you sure you want to cancel?
Portfolio
See how trades would have performed from years past or start from the present
Data archive
Download PDF copies of reports from the newspaper markets data page
World markets
View the performance of global markets and browse news items by region
Equities screener
Find companies based on country, sector, and other equity characteristics
Funds overview
View funds that move the market, screen for funds and read relevant news

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Cryoport Inc

Select symbol

Cryoport Inc

ApplyActions

About the company

Mergers & acquisitions